Xtant Medical Holdings (XTNT) EPS (Weighted Average and Diluted) (2010 - 2025)
Xtant Medical Holdings (XTNT) reported EPS (Weighted Average and Diluted) of $0.0 for Q4 2025, up 101.9% year-over-year from $0.0 in Q4 2024, and down 96.2% quarter-over-quarter from $0.01 in Q3 2025.
Xtant Medical Holdings (XTNT) EPS (Weighted Average and Diluted) (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 16 years of EPS (Weighted Average and Diluted) data on file, last reported at $0.0 in Q4 2025.
- EPS (Weighted Average and Diluted) for Q4 2025 came in at $0.0, up 101.9% year-over-year; the trailing twelve-month figure through Dec 2025 was $0.0 (up 100.32% YoY), and the FY2025 annual result was $0.03, up 127.62% from the prior year.
- EPS (Weighted Average and Diluted) declined to $0.0 in Q4 2025 per XTNT's latest filing, from $0.01 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $0.07 in Q3 2023 and troughed at -$0.04 in Q3 2024.
- A 5-year average of -$0.01 and a median of -$0.02 in 2021 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2022 and 2023: EPS (Weighted Average and Diluted) sank 8305.06% in 2022, then soared 333.33% in 2023.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.03 in 2021, then soared by 33.33% to -$0.02 in 2022, then sank by 50.0% to -$0.03 in 2023, then soared by 33.33% to -$0.02 in 2024, then jumped by 101.9% to $0.0 in 2025.
- Business Quant data shows XTNT's EPS (Weighted Average and Diluted) at $0.0 in Q4 2025, $0.01 in Q3 2025, and $0.02 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | Xtant Medical Holdings | 60.86 Mn | 43.54 Mn | 17.75 Mn | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | -0.02 |
| Sep 30, 2024 | -0.04 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | -0.03 |
| Dec 31, 2023 | -0.03 |
| Sep 30, 2023 | 0.07 |
| Jun 30, 2023 | -0.02 |
| Mar 31, 2023 | -0.02 |
| Dec 31, 2022 | -0.02 |
| Sep 30, 2022 | -0.03 |
| Jun 30, 2022 | -0.02 |
| Mar 31, 2022 | -0.03 |
| Dec 31, 2021 | -0.03 |
| Sep 30, 2021 | -0.02 |
| Jun 30, 2021 | -0.01 |
| Mar 31, 2021 | 0.00 |